Analysed MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) News Sources
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models
18-03-2026
yahoo.com
TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer
07-04-2026
yahoo.com
TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
09-04-2026
yahoo.com
TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
28-04-2026
yahoo.com
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
04-05-2026
yahoo.com
TriSalus (TLSI) Initiates Patient Enrollment for PREDICTT Liver Tumor Clinical Trial
10-05-2026
yahoo.com
What is the current price of MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ)?
The current price of MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) is $0.5559.
MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) absolute price change since previous trading day?
The absolute price change of MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) since the previous trading day is $-0.1122.
MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) percentage price change since previous trading day?
The percentage price change of MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) since the previous trading day is -16.7939%.
What is the most recent average sentiment score for MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ)?
The most recent average sentiment score for MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ)?
The most recent sentiment for MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ) is .
SEC-8K** Filing Available For MEDTECH ACQUISITION CORP-CW (TLSIW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.